Chemical function based pharmacophore models as suitable filters for virtual 3D-database screening

Journal of Molecular Structure: THEOCHEM

Volumn 503, Issue 1-2, 2000, Pages 59-72

  Langer, T ^a   Hoffmann, R D ^b   Bachmair, F ^a   Begle, S ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b Molecular Simulations Inc   (France)

Author keywords

3D database; Chemical feature based pharmacophores; Virtual screening

Indexed keywords

4 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 ANTHRYL)BENZOIC ACID; ALDEHYDE REDUCTASE; AM 93; ANTINEOPLASTIC AGENT; ARACHIDONIC ACID; ASEANOSTATIN P 5; AT 346; BOSWELLIC ACID ALPHA; BOSWELLIC ACID BETA; BOSWELLIC ACID GAMMA; BRL 35390; BROMOPALMITIC ACID 2; CALENDULIC ACID; CATALPIC ACID; CD 1530; CD 1905; CD 235; CHAULMOOGRIC ACID; CLOMOXIR; CV 5356; DECANOIC ACID; DILLENIC ACID E; HALOXYFOP; RETINAL; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOL; SALICYLIC ACID HEXYL ESTER; UNCLASSIFIED DRUG; UNINDEXED DRUG; YOHIMBINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DATA BASE; DIABETES CONTROL; DRUG ACTIVITY; DRUG SCREENING; DRUG STRUCTURE; MOLECULAR MODEL; PHARMACOPHORE; STRUCTURE ACTIVITY RELATION;

EID: 0034625097     PISSN: 01661280     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-1280(99)00363-2     Document Type: Article

References (34)

1. Wermuth C.G., Langer T. Kubinyi H. Pharmacophore Identification. 1993;117 Escom, Leiden.
2. Golender V.E., Vorpagel E.R. Kubinyi H. Computer-Assisted Pharmacophore Identification. 1993;137 Escom, Leiden.
3. Martin Y.C., Bures M.G., Danaher E.A., DeLazzer J., Lico I., Pavlik P.A. J. Comput.-Aided Mol. Des. 7:1993;83.
4. Beusen D. Tripos Tech. Notes. 1996;1.
5. Golender V., Vesterman B., Eliyahu O., Kardash A., Kletzin M. Sanz F., Giraldo J., Manaut F. Knowledge Engeneering Approach to Drug Design and its Implementation in the Apex-3D Expert System. 1994;Prous Science, Barcelona.
6. Greene J., Kahn S., Savoj H., Sprague P., Teig S. J. Chem. Inf. Comput. Sci. 34:1994;1297.
7. CATALYST, Version 4.0, MSI Inc.: Burlington, MA, USA, 1995.
8. Sprague P.W., Hoffmann R. Van de Waterbeemd H., Testa B., Folkers G. CATALYST Pharmacophore Models and their Utility as Queries for Searching 3D Databases. 1997;225 Wiley-VCH, Weinheim.
9. Giguère V. Endocrine Rev. 15:1994;61.
10. Evans R.M. Science. 240:1988;889.
11. Kilgman A.M., Grove G.L., Hirose R., Leyden J.J. J. Am. Acad. Dermatol. 15:1986;836.
12. Boone C.W., Kelloff G.J., Malone W.E. Cancer Res. 50:1990;2.
13. Widschwendter W., Daxenbichler G., Dapunt O., Marth C. Cancer Res. 55:1995;2135.
14. Bachmair F., Hoffmann R.D., Daxenbichler G., Langer T. Litwack G. Studies on Structure Activity Relationships of Retinoic Acid Receptor Ligands by Means of Molecular Modelling. 1999;159 Academic Press, San Diego.
15. Cramer R.D. III, Patterson D.E., Bunce J.D. J. Am. Chem. Soc. 110:1988;5959.
16. Derwent World Drug Index, Version 96.2, Derwent Ltd., London, 1996.
17. Bernard B.A., Bernardon J.-M., Delescluse C., Martin B., Lenoir M.-C., Maignan J., Charpentier B., Pilgrim W.R., Reichert U., Shroot B. Biochem. Biophy. Res. Commun. 186:1992;977.
18. Ghosh J., Myers C.E. Biochem. Biophys. Res. Commun. 235:1997;418.
19. Hermann J.L., Menter D.G., Beham A., Eschenbach A.V., McDonnel T.J. Exp. Cell Res. 234:1997;442.
20. Han R. Stem. Cells Dayt. 12:1994;53.
21. Scott W.T., Yano B.L., Williams D.M., Barnard S.D., Hannah M.A., Cieszlak F.S., Herman J.R. Fundam. Appl. Toxicol. 28:1995;71.
22. Iversen L., Svendsen M., Kragballe K. Acta Derm.Venereol. 76:1996;424.
23. Kador P.F. Med. Chem. Rev. 8:1988;325.
24. Tomlinson D.R., Stevens E.J., Diemel L.T. Trends Pharmacol. Sci. 1994;293.
25. Dvornik D. Aldose reductase inhibition. An approach to the prevention of diabetic complications. 1987;McGraw-Hill, New York.
26. S. Begle, Diploma thesis, University of Innsbruck, Innsbruck, 1999.
27. Yong L.S., Pearlstein R., Kador P.F. J. Med. Chem. 37:1994;787.
28. Kotani T., Nagaki Y., Ishii A., Konishi Y., Yago H., Suehiro S., Okokado N., Okamoto K.J. Med. Chem. 40:1997;684.
29. Sato S., Kador P.F. Biochem. Pharmacol. 40:1990;1033.
30. Yamaguchi T., Miura K., Usui T., Unno R., Matsumoto Y., Fukushima M., Mizuno K., Kondo Y., Baba Y., Kurono M. Arzneimi.-Forsch./Drug Res. 44:1994;344.
31. Murakami N., Ohta M., Kato K., Nakayama K., Mizota M., Miwa I., Okuda J. Arzneim.-Forsch./Drug Res. 47:1997;1222.
32. Mylari B.L., Beyer T.A., Siegel T.W. J. Med. Chem. 34:1991;1011.
33. Smellie A., Teig S.L., Towbin P.-C. J. Comp. Chem. 16:1995;171.
34. Urzhumtsev A., Tete-Favier F., Mitschler A., Barbanton J., Barth P., Urzhumtseva L., Biellmann J.F., Podjarny A.D., Moras D. Structure. 5:1997;601.